The world's first clinical trial for an aplastic anemia patient with thrombocytopenia administering platelets generated from autologous iPS cells

Int J Hematol. 2019 Feb;109(2):239-240. doi: 10.1007/s12185-018-02565-y. Epub 2018 Dec 7.

Akira Akabayashi^{1

2}, Eisuke Nakazawa³, Nancy S Jecker^{4

5}

¹ Department of Biomedical Ethics, Faculty of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan. akirasan-tky@umin.ac.jp.
² Division of Medical Ethics, Department of Population Health, New York University School of Medicine, New York, NY, 10016, USA. akirasan-tky@umin.ac.jp.
³ Department of Biomedical Ethics, Faculty of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan.
⁴ Department of Bioethics and Humanities, University of Washington School of Medicine, Seattle, WA, 98195-7120, USA.
⁵ African Centre for Epistemology and Philosophy of Science, University of Johannesburg, Johannesburg, South Africa.

No abstract available

Publication types